Similar Papers

Paper Title
Journal
Date
Author
Converting Nonhydrolyzable Nucleotides to Strong Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Agonists by Gain of Function (GOF) Mutations
George Okeyo ... Kevin L Kirk
Journal of Biological Chemistry | VOL. 288
George Okeyo, et. al.George Okeyo ... Kevin L Kirk
01 Jun 2013
Activating Mutations in Protein Tyrosine Phosphatase Ptpn11 (Shp2) Enhance Reactive Oxygen Species Production That Contributes to Myeloproliferative Disorder
Dan Xu ... Hong Zheng
PLoS ONE | VOL. 8
Dan Xu, et. al.Dan Xu ... Hong Zheng
10 May 2013
Comprehensive analysis of MET mutations in NSCLC patients in a real-world setting.
Xinghao Ai ... Jing Bai
Therapeutic advances in medical oncology | VOL. 14
Xinghao Ai, et. al.Xinghao Ai ... Jing Bai
01 Jan 2021
GDF5 is associated with a variety of skeletal malformations due to gain or loss of function mutations
E Degenkolbe ... P Seemann
Bone | VOL. 51
E Degenkolbe, et. al.E Degenkolbe ... P Seemann
06 Oct 2012
View more papers

More From: Vascular Pharmacology

Paper Title
Journal
Date
Author
Elucidating emerging signaling pathways driving endothelial dysfunction in cardiovascular aging.
Anna De Bartolo ... Carmine Rocca
Vascular pharmacology | VOL. -
Anna De Bartolo, et. al.Anna De Bartolo ... Carmine Rocca
11 Jan 2025
Stay connected: The myoendothelial junction proteins in vascular function and dysfunction
Giulia Querio ... Pasquale Pagliaro
Vascular Pharmacology | VOL. -
Giulia Querio, et. al.Giulia Querio ... Pasquale Pagliaro
01 Jan 2025
Endostatin in disease modulation: From cancer to beyond.
J Anakha ... Abhay H Pande
Vascular pharmacology | VOL. -
J Anakha, et. al.J Anakha ... Abhay H Pande
19 Dec 2024
Interplay between CD28 and PD-1 in T cell immunotherapy.
Zuhayr Jafri ... Levon M Khachigian
Vascular pharmacology | VOL. -
Zuhayr Jafri, et. al.Zuhayr Jafri ... Levon M Khachigian
01 Dec 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.